1. Ringvold, A, Vik, E, Bevanger, LS. Moraxella lacunata isolated from epidemic conjunctivitis among teen-aged females. Acta Ophthalmol (Copenh). 1985;63:427-431.
Google Scholar | Crossref | Medline2. Hoarau, G, Merabet, L, Brignole-Baudouin, F, Mizrahi, A, Borderie, V, Bouheraoua, N. Moraxella keratitis: epidemiology and outcomes. Eur J Clin Microbiol Infect Dis. 2020;39:2317-2325.
Google Scholar | Crossref | Medline3. Pavlatou, M, Athanasiades, T. A case of acute meningitis due to Moraxella lacunata. Helv Paediatr Acta. 1953;8:104-106.
Google Scholar | Medline4. Sanyal, SK, Wilson, N, Twum-Danso, K, Abomelha, A, Sohel, S. Moraxella endocarditis following balloon angioplasty of aortic coarctation. Am Heart J. 1990;119:1421-1423.
Google Scholar | Crossref | Medline5. Nagano, N, Sato, J, Cordevant, C, Nagano, Y, Taguchi, F, Inoue, M. Presumed endocarditis caused by BRO beta-lactamase-producing Moraxella lacunata in an infant with Fallot’s tetrad. J Clin Microbiol. 2003;41:5310-5312.
Google Scholar | Crossref | Medline6. Sawada, N, Morohashi, T, Mutoh, T, et al. Moraxella lacunata infection accompanied by acute glomerulonephritis. Open Med. 2020;15:962-967.
Google Scholar | Crossref7. Wijnsma, KL, Duineveld, C, Wetzels, JFM, van de Kar, NCAJ. Eculizumab in atypical hemolytic uremic syndrome: strategies toward restrictive use. Pediatr Nephrol. 2019;34:2261-2277.
Google Scholar | Crossref | Medline8. Patriquin, CJ, Kuo, KHM. Eculizumab and beyond: the past, present, and future of complement therapeutics. Transfus Med Rev. 2019;33:256-265.
Google Scholar | Crossref | Medline9. Yüksel, S, Evrengül, H, Özçakar, ZB, et al. First-line, early and long-term eculizumab therapy in atypical hemolytic uremic syndrome: a case series in pediatric patients. Paediatr Drugs. 2016;18:413-420.
Google Scholar | Crossref | Medline10. McNamara, LA, Topaz, N, Wang, X, Hariri, S, Fox, L, MacNeil, JR. High risk for invasive meningococcal disease among patients receiving eculizumab (Soliris) despite receipt of meningococcal vaccine. MMWR Morb Mortal Wkly Rep. 2017;66:734-737.
Google Scholar | Crossref | Medline11. Crew, PE, McNamara, L, Waldron, PE, McCulley, L, Jones, SC, Bersoff-Matcha, SJ. Unusual Neisseria species as a cause of infection in patients taking eculizumab. J Infect. 2019;78:113-118.
Google Scholar | Crossref | Medline12. Crew, PE, McNamara, L, Waldron, PE, McCulley, L, Jones, SC, Bersoff-Matcha, SJ. Antibiotic prophylaxis in vaccinated eculizumab recipients who developed meningococcal disease. J Infect. 2020;80:358-361.
Google Scholar | Crossref13. Howard, JF, Utsugisawa, K, Benatar, M, et al. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalized myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study. Lancet Neurol. 2017;16:976-986.
Google Scholar | Crossref | Medline | ISI14. Goldstein, B, Giroir, B, Randolph, A, International Consensus Conference on Pediatric Sepsis . International pediatric sepsis consensus conference: definitions for sepsis and organ dysfunction in pediatrics. Pediatr Crit Care Med. 2005;6:2-8.
Google Scholar | Crossref | Medline15. Mehmeti, F, Cochard, B, Cuérel, C, et al. Moraxella lacunata subacute osteomyelitis in a child. J Pediatr Infect Dis Soc. Published online December 12, 2019. doi:10.1093/jpids/piz089
Google Scholar | Crossref | Medline16. Walker, D, Altamimi, S, Henneberry, J. Moraxella lacunata bacteremia and sepsis associated with echthyma gangrenosum: a case report and review of the literature. Infect Dis Clin Pract (Baltim Md). 2017;25:131-133.
Google Scholar | Crossref17. Konar, M, Granoff, DM. Eculizumab treatment and impaired opsonophagocytic killing of meningococci by whole blood from immunized adults. Blood. 2017;130:891-899.
Google Scholar | Crossref | Medline18. Langereis, JD, van den Broek, B, Franssen, S, et al. Eculizumab impairs Neisseria meningitidis serogroup B killing in whole blood despite 4CMenB vaccination of PNH patients. Blood Adv. 2020;4:3615-3620.
Google Scholar | Crossref | Medline